Clinical Trial Update: A Prospective Real-World Observational Study of Nanocrystalline Megestrol Acetate in Patients With Cancer Cachexia [Phase 4]

View source ↗

Summary

A Phase 4 prospective real-world observational study evaluating nanocrystalline megestrol acetate in patients with cancer cachexia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Cachexia

Drugs mentioned

• Nanocrystalline Megestrol Acetate (megestrol acetate)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Clinical Characteristics and Treatment Outcomes of Malignant Tumor Cachexia, Multicenter Observational Study | Phase 4 | Status: RECRUITING